Rare diseases
Investigational molecules
Locations
Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
AustriaStudy on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma
AustriaStudy on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension
AustriaStudy on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease
AustriaStudy of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation
AustriaStudy on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis
AustriaStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
AustriaStudy on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors
AustriaStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
AustriaStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
AustriaStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
